HEALTH TECHNOLOGY

Carestream Selects HPE GreenLake to Transform Healthcare Platform Using AI as a Service

Carestream Health | May 21, 2021

Carestream Selects HPE GreenLake to Transform Healthcare Platform Using AI as a Service

Hewlett Packard Enterprise today announced that Carestream Health, a number one global provider of medical imaging systems, has selected HPE to power a transformative new healthcare initiative supported by artificial intelligence-as-a-service (AIaaS). Based in Rochester, NY, Carestream will use HPE GreenLake for Machine Learning Operations (ML Ops), a machine learning-optimized cloud service infrastructure powered by HPE Ezmeral and HPE Pointnext AI Services. The new infrastructure enhances X-ray solutions and workflows for medical professionals and patients, facilitating the subsequent generation of AI-enabled imaging devices for diagnosis.

 

Carestreams next-generation platform leverages powerful AI technology to streamline, transform, and improve the medical imaging process, adding value across the whole imaging chain for both patients and providers. AI algorithms are wont to improve accuracy, automate radiology workflow processes, and reduce cycle times. The new AIaaS healthcare solution will accelerate development, compliance, and operational processes like deploying updates of the latest machine learning and deep learning models. Over time, hospitals using Carestreams platform are going to be ready to scale to help more patients and use mobile solutions to deal with patient needs wherever needed. Time-consuming local software updates are going to be replaced by cloud hardware and repair upgrades, enabling hospitals to evolve their medical imaging capabilities, seamlessly meeting compliance requirements.

 

HPEs collaboration with Carestream will impact medical imaging technology on a worldwide scale, as Carestreams X-ray platforms are already in use across 140 countries, spanning over 100,000 pieces of kit and 35 different hardware configurations. Deploying Carestreams robust pipeline of advanced AI algorithms across diverse legacy hardware is challenging, but HPEs hybrid cloud solution will play a key role.

 

Collaborating closely with Carestream and delivering the initial AI advisory services, HPE experts will provide Carestream a scalable, future-proof AIaaS platform to develop, deploy, monitor, and support AI models served to Carestreams edge imaging systems. HPE servers include GPUs developed by NVIDIA, a key AI hardware partner within the project, enabling each server to tackle multiple imaging and analysis tasks simultaneously. HPE and NVIDIA technology also will facilitate federated learning the aggregation of anonymized machine learning data across multiple provider facilities. Federated learning is predicted to revolutionize healthcare research and development over the subsequent decade, enabling researchers to extend diagnostic intelligence and automation without compromising patient privacy.

 

The end-to-end AIaaS platform to be delivered by HPE GreenLake was architected by HPEs Pointnext Services team as a trusted services partner, using HPE storage, servers, HPE Ezmeral software, and partner solutions like those provided by SUSE. HPE will handle the entire solution execution, including ongoing care, AI operations, and infrastructure management. The new platform will enable Carestream to scale back its AI-related research and development costs while accelerating the companys AI-powered imaging, workflow automation, and analytics innovations.

 

HPE GreenLake for ML Ops makes it easier and faster to urge started with ML/AI projects, and seamlessly scale them to production deployments. Customers can deploy AL/ML workloads on HPE's ML-optimized cloud service infrastructure, an answer that's designed to deal with all aspects of the ML lifecycle, from data preparation to model building, training, deployment, monitoring, and collaboration.

 

HPE GreenLake cloud services provide customers with a strong foundation to drive digital transformation through an elastic as-a-service platform that will run on-premises, at the sting, or during a colocation facility. Customers of all sizes will find that HPE GreenLake combines the simplicity and agility of the cloud with the governance, compliance, and visibility that comes with hybrid IT. Large enterprises will particularly appreciate that HPE GreenLake offers a variety of cloud services that accelerate innovation, including cloud services for bare metal, compute, container management, data protection, HCI, HPC, machine learning operations, networking, SAP HANA, storage, VDI, and VMs.

 

The HPE GreenLake Cloud Services business is rapidly growing, with over $4.5 billion in total contract value, and quite 830 selling partners. Today, HPE GreenLake has over 1,000 enterprise customers across 50 countries altogether industry sectors and sizes, including Fortune 500 companies, government and public sector organizations, and little and midmarket enterprises.

 

About Hewlett Packard Enterprise

Hewlett Packard Enterprise is that the global edge-to-cloud platform-as-a-service company that helps organizations accelerate outcomes by unlocking value from all of their data, everywhere. Built on decades of reimagining the longer term and innovating to advance the way people live and work, HPE delivers unique, open, and intelligent technology solutions, with a uniform experience across all clouds and edges, to assist customers to develop new business models, engage in new ways, and increase operational performance.

 

About Carestream Health

Carestream may be a worldwide provider of medical imaging systems; X-ray imaging systems for non-destructive testing; and precision contract coating services for a good range of commercial, medical, electronic, and other applicationsall backed by a worldwide service and support network.

Spotlight

Gwinnett Medical Center (GMC) is also known as Gwinnett Hospital System, Inc. (GHS) is a not-for-profit and tax-exempt organization that operates exclusively to serve the community. Our mission is to meet the healthcare needs of the community by providing quality health services. For more than 65 years, we have been committed to the underserved, uninsured and indigent populations. We are diligent in our efforts to join with physicians, community and other healthcare organizations to provide health services.


Other News
HEALTH TECHNOLOGY

The GIANT Health Event 2021. Early bird tickets on sale now

GIANT Health | October 13, 2021

Europe's greatest festival of Health Tech Innovation | 30th Nov - 1st Dec 2021 Join us at GIANT this year and immerse yourself in Europe's greatest festival of healthcare innovation. Find inspiration from global leading innovators, and discover the advances in technology that are revolutionizing healthcare provision. GIANT 2021 is set to be our biggest event yet so don't miss out. GIANT Health event is an invaluable, cost-effective global hybrid event. Combining both a real-world physical trade show and multiple conferences in central London, as well as a sophisticated and engaging virtual event based on GIANT Health’s proprietary Virtual Event Platform. Learn more about Digital Therapeutics. Would you like to network with 1000s and 1000s of Europe's leading healthcare and technology innovators, hospital leaders, health-sector investors, and entrepreneurs? Over 400 speakers will convene in 15+ conference at the massive GIANT Health Event, 30 November - 1 December, 2021. Come join us in person or remotely. Early Bird tickets are now available. CLAIM YOUR TICKET HERE A special promotional code which allows to save up to 25% on top is available for our subscribers: MEDIA25 See you there! Media contact: GIANT Health Events Ltd Olga Nosova +44 20 8144 9779 Olga@GIANT.health

Read More

HEALTH TECHNOLOGY

PulsePoint Releases Next Generation Health Media Platform With Advanced Automation And AI

PulsePoint | July 06, 2021

PulsePoint, a technology company revolutionizing health decision-making in real-time, today announced the next generation launch of its digital media buying platform, Life by PulsePoint™. Its enhanced AI and automation simplifies and supercharges the media planning, activation, and optimization processes. Designed for the self-serve programmatic trader, these updates promote efficiencies and surface predictive and in-flight campaign analytics for quick strategic decisioning to yield higher media return on investment. Built upon PulsePoint's extensive data foundation, Genome™, that proactively uses microdata to capture attention when intent is signaled, Life is the leading healthcare end-to-end programmatic platform. Life's automated machine learning and AI allows marketers to quickly create highly-customized segments that classify populations in real-time, and deliver sequential messaging to drive customer actions in the moment and across the health journey. This next generation of the Life platform includes: • Advanced media planning innovations: Life offers an AI-powered forecasting tool used to run simulations to generate predictive performance metrics and intelligent audience insights. This makes it easier for marketers to preview budgets and ideate and adjust tactics to obtain their desired campaign outcomes, all before a single dollar is spent. Each forecast is powered by detailed supply and channel insights, like expected delivery, and campaign performance can be viewed by a variety of dimensions, including creative types, domains/apps, condition categories, healthcare professional specialties, geographies, among others. • Better campaign management with advanced dashboard: An automated and real-time view of line item performance and pacing gives traders a deeper, more granular look into their campaigns, making it easier for them to optimize their spend based on flight delivery and anticipate new incremental opportunities. The dashboard not only surfaces key numbers, but it also includes dynamic performance charts to uncover real-time campaign insights. • Turnkey PMP (private marketplaces) deal builder: Enhanced with turnkey end-to-end functionality, self-serve traders can now enable the deals that they negotiated directly with publishers and/or SSPs through Life's UI, decreasing the time it takes to launch PMPs. "Life was built for the healthcare marketer to simplify and optimize marketing campaigns," said Andrew Stark, CRO of PulsePoint. "Our newest capabilities increase efficiencies through advanced forecasting and real-time performance optimization, enabling more control and enhanced campaign management." Life by PulsePoint provides access to over 110 billion daily impressions across more than 2 million health pages, reaching 1.8M+ opted-in, verified healthcare professionals and over 90% of the online U.S. population. This release is just another step in PulsePoint's journey to deliver personalized messaging at each stage of the health journey using predictive insights built on real-time data. The company was recently acquired by Internet Brands, a KKR portfolio company and owner of WebMD Health Corp. PulsePoint's teams will continue to operate as their own division from their existing hubs in New York, San Francisco, and London. About PulsePoint PulsePoint is a leading technology company that uses real-world data in real-time to optimize campaign performance and revolutionize health decision-making. Leveraging proprietary datasets and methodology, PulsePoint targets healthcare professionals and patients with an unprecedented level of accuracy—delivering unparalleled results to the clients we serve.

Read More

HEALTH TECHNOLOGY

Future Health announced today that it has completely digitalised its annual in-person event at ExCeL London

Future Health | March 02, 2021

Future Health has completely rebranded during lockdown, and the flagship face-to-face event Future Health Innovations at ExCeL is now complemented by a global virtual conference series, under the brand UK Health Week. Free for delegates to attend, it is CPD and CME accredited. Participants will be able to connect, meet buyers and partake in cross border purchasing, education and deal making, enabling an increased ROI and profitable encounters with its AI powered networking software. Further Health Weeks are being rolled out around the world over the course of the coming months, and will be territory specific. Dawn Barclay-Ross, Event Director commented: “I think there will always be a place for face-to-face events; and we are contracted with ExCeL for a live ‘in person’ event four years in advance to 2025. However, as a result of international travel restrictions, health professionals in global markets are looking for on-line engagement”. Future Health offers buyers and sellers the ability to operate on line, and to research and access the products and services that their hospitals and citizens desperately need. Dawn concluded, “In the immediate post COVID era, health buyers want to be able to operate from the comfort of their desk or smart device, and they now can, from literally anywhere in the world”. AboutFuture Health Future Health is an independent exhibition and conference organiser, based in London in the UK. For further information regarding exhibiting, visiting and sponsorship opportunities at Future Health Innovations or UK Health Week Please call +44 (0) 208 012 8511 Email: hello@futurehealthinnovations.com or to sign up to the Future Health platform, register at www.futurehealthinnovations.com

Read More

HEALTH TECHNOLOGY

L2Mtech GmbH Receives CE Mark Approval on 6(SIX) products for Cardiovascular and Endovascular Applications

L2Mtech | February 17, 2021

CE Mark Approval for LimusTrack™, Sirolimus Eluting Coronary Stent System for Cardiovascular Applications. CE Mark Approval for LomiFlow™, Paclitaxel Drug Eluting Balloon for Cardiovascular Applications CE Mark Approval for PearlFlow™, Paclitaxel Drug Elutin Balloon for Endovascular Applications CE Mark Approval for PearlFlow NS™, Self Expandable Nitinol Stent System for Endovascular Applications CE Mark Approval for FlexiTrack 018™, Peripheral Balloon Catheter for Endovascular Applications CE Mark Approval for FlexiTrack 035™, Peripheral Balloon Catheter for Endovascular Applications Bonn, Germany – L2Mtech GmbH has announced the award of its first CE Mark approval on Six (6) products: LimusTrack™ : Sirolimus Coated Cobalt Chromium Stent with biodegradable polymer for the treatment of coronary artery disease, de novo lesions, restenosis lesions. LomiFlow™ : Paclitaxel Coated balloon catheter for the treatment of coronary artery disease, small vessels, dilatation of de novo lesions, in-stent restenosis (ISR) cases. PearlFlow™ : Paclitaxel Coated balloon catheter for the treatment of peripheral arterial disease, PTA, dilatation of stenotic segments or lesions in peripheral arteries. PearlFlow NS™ : Self-Expanding Nitinol Stent System for the treatment of peripheral arterial disease, de novo lesions, lesions in femoropopliteal arteries. FlexiTrack 018™ : Peripheral Balloon Dilatation catheter for the treatment of peripheral arterial disease, dilatation of lesions in femoral, popliteal, tibial arteries. FlexiTrack 035™ : Peripheral Balloon Dilatation catheter for the treatment of peripheral arterial disease, dilatation of lesions in the SFA, femoral arteries. L2Mtech GmbH Founder and CEO Lalit Mamtani said ‘‘We are very excited to have been awarded our first CE Mark on six products, CE Mark approval represents a key milestone for L2Mtech GmbH and is a testament to the efficacy and safety of our innovative technology products for Cardiovascular and Endovascular applications.“ We now prepare to commercially launch the products in all markets where the CE Mark is recognized. With introduction of our innovative technology products in markets, we will be able to expand treatment options for the benefit of many millions of patients with coronary and peripheral artery disease around the world. About L2Mtech Founded in 2017, L2Mtech GmbH is a privately-owned multinational medical device company headquartered at Bonn, Germany. L2Mtech specializes in design, development, manufacture and commercialization of medical devices that are used by healthcare establishments globally. L2MTech will provide interventional physicians with innovative vascular devices including Drug Eluting Balloon manufactured in Europe.Our Core mission is to build a product portfolio focused on minimally invasive treatment for patients with cardiovascular,endovascular and vascular artery disease. For further information, please visit : L2MTech.de Media Contact: L2Mtech GmbH admin@L2Mtech.de +49 228 94730761

Read More

Spotlight

Gwinnett Medical Center (GMC) is also known as Gwinnett Hospital System, Inc. (GHS) is a not-for-profit and tax-exempt organization that operates exclusively to serve the community. Our mission is to meet the healthcare needs of the community by providing quality health services. For more than 65 years, we have been committed to the underserved, uninsured and indigent populations. We are diligent in our efforts to join with physicians, community and other healthcare organizations to provide health services.

Resources